SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.62+1.6%Dec 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (3785)9/17/1997 12:07:00 AM
From: nestegg   of 17367
 
Yes!...in reading your reference re: possible XOMA involvement with pseudomonas aeruginosa, only a reference was shown as follows:

"Kadyurugamuwa et al., "Interaction of Gentamicin with the A Band and B Band Lipopolysaccharides of Pseudomonas aeruginosa and Its Possible Lethal Effect", Antimicrobial Agents and Chemotherapy, 37(4):715-721 (Apr. 1993). "

Is Gentamicin a XOMA product?

Will try and look further for full copy of the reference for details.

Thanks again, and Good Luck tomorrow.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News